Session Details

[C16]Infectious Diseases

Fri. Jul 11, 2025 10:10 AM - 11:50 AM JST
Fri. Jul 11, 2025 1:10 AM - 2:50 AM UTC
Room 09

[C16-01]Quantitative analysis of effectiveness of latency reversing agent (LRA) with HIV-Tocky system

*Morihiko Mizuno1, Yorifumi Sato2, Kosaku Kitagawa1, Shingo Iwami1 (1. Nagoya University (Japan), 2. Kumamoto University (Japan))

[C16-02]The effects of human papillomavirus vaccination in Japan

Wongyeong Choi1, *Eunha Shim1 (1. Soongsil University (Korea))

[C16-03]Viral shedding and transmissibility in immunocompromised COVID-19 patients: implications for isolation strategies

*Montie Tadaharu Harrison1, Yong Dam Jeong1,2, Shingo Iwami1 (1. Nagoya University (Japan), 2. Pusan National University (Korea))

[C16-04]Modeling Mpox Transmission: Insights from Behavioral Networks and Age Heterogeneity

*Ling Xue1, Qiaojuan Jia1, Zixiao Xiong1, Yanfen Zhang1 (1. Harbin Engineering University (China))

[C16-05]Modeling clinical trial design considering differences in IC50 between in vitro and in vivo : A case study for COVID-19

*Shotaro Yamamoto1, Taiga Miyazaki2, Shoya Iwanami1, Shingo Iwami1 (1. Nagoya University (Japan), 2. University of Miyazaki (Japan))